v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (248,056) $ (48,648) $ (105,968)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 11,796 9,392 9,235
Depreciation and amortization 59,184 60,015 60,498
Non-cash lease expense 2,104 1,986 1,721
Paid-in-kind interest expense 2,680 0 0
Provision (recovery) for credit losses 165 (996) 0
Change in fair value of derivative warrant liabilities (3,839) (23,627) 10,337
Change in fair value on interest rate collar 0 0 106
Change in fair value of contingent consideration liabilities (861) 0 0
Change in fair value of embedded derivative 144 0 0
Amortization of debt issuance costs 2,370 1,712 1,575
Amortization and release of related party liability 0 (5,856) (4,058)
Loss on extinguishment of debt 24,398 0 0
Deferred income taxes (17,444) (1,185) (7,021)
Loss on impairment of goodwill 152,018 5,031 0
Loss on acquisition 6,233 0 0
Gain on sale of trademark (5,679) 0 0
Loss on impairment of right of use assets 0 0 3,643
Loss on disposal of equipment 0 112 62
Changes in operating assets and liabilities:      
Accounts receivable (2,696) (3,158) (2,071)
Related party accounts receivable 263 309 (816)
Inventories (867) 2,580 (1,300)
Prepaid expenses 318 (2,236) 996
Other current assets and other assets 158 (377) 138
Accounts payable (6,802) (2,982) 4,382
Related party accounts payable 0 (18) (354)
Operating lease liabilities (3,002) (2,677) (2,560)
Other current liabilities and other liabilities 14,599 1,803 1,680
Net cash used in operating activities (12,816) (8,820) (29,775)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Capital expenditure on intangible assets (237) (304) (455)
Capital expenditure on property and equipment (3,430) (2,708) (1,591)
Proceeds from sale of trademark 82,500 0 0
Acquisition of Novaestiq (2,605) 0 0
Cash received from interest rate collar premium 0 92 52
Net cash provided by (used in) investing activities 76,228 (2,920) (1,994)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from PIPE investments 0 0 70,000
Payment of PIPE transaction costs 0 0 (1,068)
Proceeds from term loan, net of discount 396,063 0 0
Repayment of term loan (405,343) (8,750) (8,777)
Proceeds from revolving credit facility, net of discount 44,325 15,000 35,000
Repayment of revolving credit facility (60,000) 0 (49,117)
Proceeds from note payable 1,517 1,632 2,420
Repayment of note payable (1,575) (1,770) (1,452)
Payment of debt issuance costs (10,153) 0 0
Payment of debt termination fees (11,604) 0 0
RSU taxes paid on behalf of employees (451) (530) (1,473)
Distribution to pay withholding taxes 0 0 (1,204)
Net cash (used in) provided by financing activities (47,221) 5,582 44,329
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 16,191 (6,158) 12,560
Effect of foreign exchange rates on cash and cash equivalents (601) (116) (147)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - Beginning of period 16,302 22,576 10,163
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - End of period 31,892 16,302 22,576
SUPPLEMENTAL CASH FLOW DATA – CASH PAID:      
Interest 21,425 15,125 17,331
NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Non-cash portion of distribution agreement acquired 29,781 0 0
Capital expenditures in accounts payable and accruals 219 146 318
Issuance of stock for acquisition 7,556 0 0
Contingent consideration (Equity classified) 21,881 0 0
Initial measurement of embedded derivatives 12,553 0 0
Accrued but unpaid debt issuance costs 1,000 0 0
Deferred tax liability on acquisition 6,482 0 0
Reconciliation of cash, cash equivalents and restricted cash. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows:      
Cash and cash equivalents 30,379 14,802 21,089
Restricted cash 1,513 1,500 1,487
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows $ 31,892 $ 16,302 $ 22,576